3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
7
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
GATA2 Deficiency
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
BRCA1 Mutation
1
Anemia, Refractory, with Excess of Blasts
1
Allogeneic Stem Cell Transplantation
1
Interventions
Dexamethasone
64
Lenalidomide
37
daratumumab
34
pomalidomide
31
Bortezomib
31
Specimen Handling
25
carfilzomib
23
Biopsy
23
Cyclophosphamide
21
Magnetic Resonance Spectroscopy
18
Calcium Dobesilate
18
isatuximab
14
fludarabine
12
dexamethasone acetate
11
dexamethasone 21-phosphate
11
auricularum
11
talquetamab
10
iberdomide
10
belantamab mafodotin
10
selinexor
8
Melphalan
8
tocilizumab
7
X-Rays
7
fludarabine phosphate
6
elotuzumab
6
Nuclear Medicine Department, Hospital
5
trametinib
4
pembrolizumab
4
nirogacestat
4
Sirolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
decitabine and cedazuridine drug combination
×
30 days
×
Clear all
No trials found.